A Phase II Study of Monalizumab and Durvalumab in Patients with Recurrent/metastatic (RM) Squamous Cell Carcinoma of the Head and Neck (SCCHN): Results of the I2 Cohort of the EORTC-HNCG-1559 Trial (UPSTREAM)
ANNALS OF ONCOLOGY(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined